|1 Table of Contents
|1.1 List of Tables
|1.2 List of Figures
2 Introduction
2.1 Infusion Systems Overview
3 Products under Development
3.1 Infusion Systems – Pipeline Products by Stage of Development
3.2 Infusion Systems – Pipeline Products by Segment
3.3 Infusion Systems – Pipeline Products by Territory
3.4 Infusion Systems – Pipeline Products by Regulatory Path
3.5 Infusion Systems – Pipeline Products by Estimated Approval Date
3.6 Infusion Systems – Ongoing Clinical Trials
4 Infusion Systems – Pipeline Products under Development by Companies
4.1 Infusion Systems Companies – Pipeline Products by Stage of Development
4.2 Infusion Systems – Pipeline Products by Stage of Development
5 Infusion Systems Companies and Product Overview
5.1 410 Medical Inc Company Overview
5.1.1 410 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 AbbVie Inc Company Overview
5.2.1 AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Acuros GmbH Company Overview
5.3.1 Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.4 Adept Medical Ltd Company Overview
5.4.1 Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Agitated Solutions LLC Company Overview
5.5.1 Agitated Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 Albireo Pharma Inc Company Overview
5.6.1 Albireo Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Alnylam Pharmaceuticals Inc Company Overview
5.7.1 Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Arnali, LLC Company Overview
5.8.1 Arnali, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Avoset Health Ltd Company Overview
5.9.1 Avoset Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.10 Baxter Healthcare Corp Company Overview
5.10.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview
5.11 Baxter International Inc Company Overview
5.11.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Becton Dickinson and Co Company Overview
5.12.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
5.13 BioQ Pharma Inc Company Overview
5.13.1 BioQ Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 ClearLine MD (Inactive) Company Overview
5.14.1 ClearLine MD (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.15 Cognos Therapeutics Inc Company Overview
5.15.1 Cognos Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Debiotech SA Company Overview
5.16.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
5.17 Eksigent Technologies, LLC Company Overview
5.17.1 Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.18 Eli Lilly and Co Company Overview
5.18.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
5.19 EryDel SPA Company Overview
5.19.1 EryDel SPA Pipeline Products & Ongoing Clinical Trials Overview
5.20 Flowonix Medical Inc Company Overview
5.20.1 Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Fluid Synchrony LLC Company Overview
5.21.1 Fluid Synchrony LLC Pipeline Products & Ongoing Clinical Trials Overview
5.22 Fluonic, Inc. (Inactive) Company Overview
5.22.1 Fluonic, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.23 Fresenius Medical Care AG & Co KGaA Company Overview
5.23.1 Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview
5.24 Gerresheimer AG Company Overview
5.24.1 Gerresheimer AG Pipeline Products & Ongoing Clinical Trials Overview
5.25 HAI Solutions Inc Company Overview
5.25.1 HAI Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Hospira Inc Company Overview
5.26.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 Hospital for Special Surgery Company Overview
5.27.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
5.28 ICU Medical Inc Company Overview
5.28.1 ICU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 Infusense Corp Company Overview
5.29.1 Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview
5.30 Innofuse BV Company Overview
5.30.1 Innofuse BV Pipeline Products & Ongoing Clinical Trials Overview
5.31 Innoveren Scientific Inc Company Overview
5.31.1 Innoveren Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Innovfusion Pte. Ltd. Company Overview
5.32.1 Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.33 Intarcia Therapeutics Inc Company Overview
5.33.1 Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Intex Technologies (India) Ltd Company Overview
5.34.1 Intex Technologies (India) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 IRadimed Corp Company Overview
5.35.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
5.36 KORU Medical Systems Inc Company Overview
5.36.1 KORU Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 LifeMedix, LLC Company Overview
5.37.1 LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.38 Liquidia Corp Company Overview
5.38.1 Liquidia Corp Pipeline Products & Ongoing Clinical Trials Overview
5.39 Lynntech Inc Company Overview
5.39.1 Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.40 Massachusetts Institute of Technology Company Overview
5.40.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.41 Medical Device Creations Ltd. Company Overview
5.41.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.42 MonuMedical LLC Company Overview
5.42.1 MonuMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.43 Neurochase Ltd Company Overview
5.43.1 Neurochase Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.44 NexGen Medical Systems Inc Company Overview
5.44.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.45 Palyon Medical Corp (Inactive) Company Overview
5.45.1 Palyon Medical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.46 Pavmed Inc Company Overview
5.46.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.47 Pneuma Systems Corp Company Overview
5.47.1 Pneuma Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
5.48 PRO-IV Medical Ltd Company Overview
5.48.1 PRO-IV Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.49 Ratio Inc Company Overview
5.49.1 Ratio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.50 Rice University Company Overview
5.50.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview
5.51 Shenox Pharmaceuticals LLC Company Overview
5.51.1 Shenox Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
5.52 Shift Labs Inc Company Overview
5.52.1 Shift Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
5.53 SQ Innovation AG Company Overview
5.53.1 SQ Innovation AG Pipeline Products & Ongoing Clinical Trials Overview
5.54 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.54.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.55 Starton Therapeutics Inc Company Overview
5.55.1 Starton Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.56 SteadyMed Therapeutics Inc Company Overview
5.56.1 SteadyMed Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.57 StnDrd Infusion Corporation Company Overview
5.57.1 StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.58 Supernus Pharmaceuticals Inc Company Overview
5.58.1 Supernus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.59 Terumo Corp Company Overview
5.59.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.60 ToucheMedical Ltd. Company Overview
5.60.1 ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.61 TriSalus Life Sciences Inc Company Overview
5.61.1 TriSalus Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.62 Turnpoint Medical Devices Inc Company Overview
5.62.1 Turnpoint Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.63 U-Needle BV Company Overview
5.63.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview
5.64 Unilife Corporation Company Overview
5.64.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.65 United Therapeutics Corp Company Overview
5.65.1 United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.66 University of Minnesota Company Overview
5.66.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.67 University of Southern California Company Overview
5.67.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
5.68 Zealand Pharma AS Company Overview
5.68.1 Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview
6 Infusion Systems- Recent Developments
6.1 Sep 13, 2024: Baxter Healthcare Receives Additional 510(K) Clearance For Novum IQ Syringe Pump
6.2 Sep 13, 2024: sfm medical devices Receives Additional 510(K) Clearance For nextaro va
6.3 Sep 09, 2024: Eli Lilly Promotes Lucas Montarce to CFO
6.4 Sep 09, 2024: Baxter Names Former Auto Exec Jay Craig to Its Board
6.5 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024
6.6 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
6.7 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
6.8 Aug 20, 2024: Infusion Pump Battery Correction: ICU Medical Updates Instructions for Use Regarding Batteries in Plum 360, A+ and A+3 Infusion System due to Diminished Battery Life that May Impact Infusion Delivery
6.9 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
6.10 Aug 12, 2024: Pneuma Systems wins FDA STeP support for infusion pump control system
6.11 Aug 06, 2024: Innovative Health Sciences to market syringe infusion system
6.12 Aug 06, 2024: Ambulatory Infusion Pump Software Correction: Smiths Medical Issues Correction for CADD-Solis and CADD-Solis VIP Ambulatory Infusion Pump Software due to Multiple Issues Related to Outdated Software
6.13 Aug 02, 2024: Moog Announces Q3 2024 Results
6.14 Aug 01, 2024: 3M Names Anurag Maheshwari as Executive Vice President and Chief Financial Officer
6.15 Aug 01, 2024: TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
6.16 Jul 26, 2024: 3M Delivers Strong Second-Quarter Results; Company Updates Full-Year 2024 Earnings Guidance
6.17 Jul 25, 2024: IRADIMED to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
6.18 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
6.19 Jul 10, 2024: 3M Announces Departure of Chief Financial Officer
6.20 Jul 04, 2024: Epic Medical Receives An Additional 510(K) Clearance For eZSURE Empty Fluid Container with ProSeal Injection Site
6.21 Jul 03, 2024: Koru Medical’s FreedomEdge infusion system receives approval in Japan
6.22 Jun 25, 2024: United Therapeutics Receives Additional 510(K) Clearance For RemUnity System
6.23 Jun 13, 2024: Medtronic Confirms Global Layoffs
6.24 Jun 04, 2024: KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
6.25 Jun 03, 2024: Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
6.26 May 30, 2024: Moog Receives FDA 510(k) Clearance for Curlin 8000 Ambulatory Infusion System
6.27 May 30, 2024: OptumHealth Care Solutions Recalls Nimbus II Infusion Pump Systems Under Recall by InfuTronix
6.28 May 21, 2024: Hospira Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection Carpuject Units And Labetalol Hydrochloride Injection, Usp Carpuject Units Due To The Potential For Incomplete Crimp Seals
6.29 May 17, 2024: West Pharmaceutical Services Receives Additional 510(K) Clearance For Vial2Bag Advanced 20mm Admixture Device
6.30 May 14, 2024: KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
6.31 May 13, 2024: Novo Nordisk Plans Bond Sale to Fund Expansion
6.32 May 09, 2024: Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow EZ-IO Intraosseous Access Procedure Tray
6.33 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference
6.34 May 02, 2024: Novo Nordisk’s Sales Increased by 22% in Danish kroner and by 24% at Constant Exchange Rates to DKK
65.3 billion in the First Three Months of 2024
6.35 May 02, 2024: IRadimed Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
6.36 May 02, 2024: ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
6.37 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
6.38 Apr 27, 2024: Moog Reports Results for the Quarter Ended in March – Earnings Summary
6.39 Apr 25, 2024: Infutronix Recalls Nimbus and Nimbus II Infusion Pump Systems for Multiple Device Failures That May Cause Severe Injury and Death
6.40 Apr 17, 2024: Fresenius Kabi USA Recalls Ivenix Infusion Pump Lvp Software for Anomalies That Have the Potential to Cause Serious Patient Harm or Death
6.41 Apr 16, 2024: Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results
6.42 Apr 08, 2024: Supernus Provides Regulatory Update for SPN-830
6.43 Apr 01, 2024: Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
6.44 Mar 21, 2024: Pavmed Launches Incubator to Advance Existing Pipeline Technologies Including PortIO, EsoCure and CarpX
6.45 Mar 20, 2024: Voluntary Removal Announcement for the InfuTronix Nimbus Ambulatory Infusion Pump System
6.46 Mar 20, 2024: Cencora Partners with WeInfuse to Bolster Infusion Strategy
6.47 Mar 18, 2024: KORU Medical Systems to Present Data Demonstrating 97% Adherence on its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
6.48 Mar 18, 2024: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina
6.49 Mar 13, 2024: 3M Names New CEO Amid PFAS Battles, Health Spinoff
6.50 Mar 12, 2024: 3M Announces New Leadership Appointments
6.51 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
6.52 Mar 11, 2024: Innovative Health Sciences Receives FDA 510(k) Clearance for Insignis Syringe Infusion System
6.53 Mar 11, 2024: DEKA Research and Development Receives FDA 510(k) Clearance for Infusion System
6.54 Mar 10, 2024: DEKA Research and Development Receives 510(K) Clearance For Administration Set
6.55 Mar 06, 2024: KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
6.56 Mar 06, 2024: KORU Medical Systems to Release Quarterly Earnings on Wednesday, March 13th
6.57 Mar 05, 2024: Smiths Medical Recalls Medfusion Model 3500 Syringe Pump Due to Issues Associated with Earlier Software Versions
6.58 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
6.59 Feb 27, 2024: Alnylam to Webcast Presentations at Upcoming March Investor Conferences
6.60 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
6.61 Feb 22, 2024: eMed Technologies Receives Additional 510(K) Clearance for the SCIg60 Infusion System
6.62 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
6.63 Jan 30, 2024: Ballad Health partners with 410 Medical for rapid fluid delivery
6.64 Jan 30, 2024: Hepatic Artery Infusion (HAI) Therapy is Now Available Nationwide in More Than 65 Medical Centers
6.65 Jan 16, 2024: Independent Research Data On Hepatic Artery Infusion (HAI) Therapy To Be Featured At ASCO GI Cancer Symposium
6.66 Jan 16, 2024: 3M Picks Former NuVasive CEO as President of Medical Solutions
6.67 Jan 12, 2024: Fresenius Kabi USA Recalls Ivenix Large Volume Pump (LVP) of the Ivenix Infusion System Due to Mechanical Interference
6.68 Jan 09, 2024: Nura Pain Clinics Physician Treats First Patient in Minnesota with New Medtronic SynchroMed III Targeted Drug Delivery System for Pain
6.69 Jan 04, 2024: Jiangsu Kangbao Medical Experiment Receives 510(K) Clearance For Winged Infusion Set
6.70 Jan 04, 2024: Jiangsu Kangbao Medical Experiment Receives 510(K) Clearance For Safety Winged Infusion Set
6.71 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
6.72 Dec 20, 2023: West Pharmaceutical Services Receives Additional 510(k) Clearance for Vial2Bag Direct Connect
6.73 Dec 19, 2023: Becton Dickinson (BD)/Carefusion 303 Recalls Alaris Infusion Pumps Due to Compatibility Issues with Cardinal Health Monoject Syringes
6.74 Dec 14, 2023: eMed Technologies Receives FDA 510(k) Clearance for VersaPump Infusion System
6.75 Dec 14, 2023: Fresenius Kabi and Mayo Clinic Enter into Multiyear Supply and Service Agreement for the Ivenix Infusion System
6.76 Dec 05, 2023: West obtains FDA approval for Vial2Bag admixture device
6.77 Nov 30, 2023: Baxter Issues Urgent Medical Device Correction for Novum IQ Syringe Infusion Pump Due to Potential Impact of Downstream Occlusions on Infusion Volume
6.78 Nov 27, 2023: Unomedical A/S Recalls Varisoft Infusion Sets Due to Damage to the Connector Piece Causing Unexpected Disconnections
6.79 Nov 14, 2023: KORU Medical Systems Receives Additional 510(K) Clearance For FREEDOM60
6.80 Nov 14, 2023: KORU Medical Systems Receives Additional 510(K) Clearance For HIgH-Flo Super26 Subcutaneous Safety Needle Set
6.81 Nov 14, 2023: KORU Medical Systems Receives Additional 510(K) Clearance For HIgH-Flo Subcutaneous Safety Needle Set
6.82 Nov 09, 2023: 3M Announces Leadership Changes
6.83 Nov 08, 2023: Koru Medical Systems Announces Development Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
6.84 Nov 07, 2023: Koru Medical Systems Receives FDA 510(K) Clearance for FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes
6.85 Nov 07, 2023: Tom Sweet Elected to 3M Board of Directors
6.86 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
6.87 Oct 26, 2023: Lilly to Participate in UBS Biopharma Conference 2023
6.88 Oct 24, 2023: 3M Reports Third Quarter 2023 Results; Company Increases Full Year Adjusted Earnings and Cash Flow Expectations
6.89 Oct 20, 2023: Lilly Confirms Date and Conference Call for Third-Quarter 2023 Financial Results Announcement
6.90 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
6.91 Oct 10, 2023: Medtronic Receives FDA Approval for Synchromed III Intrathecal Drug Delivery System for Chronic Pain, Cancer Pain, and Severe Spasticity
6.92 Oct 09, 2023: Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
6.93 Oct 05, 2023: KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
6.94 Oct 02, 2023: Fresenius Kabi Selected for Second Consecutive Year to Exhibit the Ivenix Infusion System at Vizient Innovative Technology Exchange
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
Buy the Full Report for More Company Insights into the Infusion Systems Pipeline Market
